<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82787">
  <stage>Registered</stage>
  <submitdate>29/04/2008</submitdate>
  <approvaldate>2/05/2008</approvaldate>
  <actrnumber>ACTRN12608000228381</actrnumber>
  <trial_identification>
    <studytitle>Randomised controlled trial of combined cognitive behavioural therapy for alcohol use problems and social phobia</studytitle>
    <scientifictitle>For comorbid alcohol use and social anxiety disorders does combined cognitive behavioural therapy (CBT) do better than CBT for alcohol alone in improving symptoms of either anxiety or alcohol or quality of life</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>comorbid Social anxiety disorder and alcohol use disorder</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Anxiety</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Addiction</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cognitive behaviour therapy combining cognitive therapy for social anxiety disoder, and motivational interviewing and CBT based coping skills for alcohol use disorders in eight two hour group sessions</interventions>
    <comparator>Cognitive behaviour therapy for alcohol use disorders in eight two hour group sessions</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Symptoms of social anxiety disorder as assessed by a composite of the Social Phobia Scale and Social Interaction Anxiety scale, Brief Fear of Negative Evaluation Scale, and Social Phobia subscale of the Albany Panic and Phobia Questionnaire</outcome>
      <timepoint>3 and six months post treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Symptoms of Alcohol use disorders, alcohol consumption, alcohol related problems, alcohol dependence as assessd by the number of tandard drinks per drinking occasion, assessed using the Time Line Follow Back procedure, and the Severity of Alcohol Dependence Questionnaire.</outcome>
      <timepoint>three and six months post treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of Life as assessed by the Short Form 12 (SF-12)</outcome>
      <timepoint>three and six months post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>symptoms of depression as assessed by the Depression, Anxiety, and Stress Scales</outcome>
      <timepoint>three and six months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>adults (aged 18 years and older) who consume alcohol at harmful levels (men consuming 29 standard drinks of alcohol per week or more and women 14 standard drinks per week or more) and have a current (DSM-IV) diagnosis of social phobia; have a basic literacy and ability to communicate in English</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Active or florid psychosis,
History of schizophrenia spectrum disorder or bipolar disorder,
Current active suicidal intent,
Current injecting drug use, 
Dependence on benzodiazepines or other substances (other than tobacco)  
Need for intensive detoxification (a score = 20 on CIWA-AR)  (upon completion of detoxification participants will be eligible for inclusion),
Inability to provide locator information or inability to participate in treatment and booster sessions</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/07/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Andrew Baillie</primarysponsorname>
    <primarysponsoraddress>Psychology Department
Macquarie University NSW 2109</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC Project Grant</fundingname>
      <fundingaddress>National Health and Medical Research Council
Canberra</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Claudia Sannibale</sponsorname>
      <sponsoraddress>National Drug and Alcohol Research Centre
University of New South Wales NSW 2055</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>14/03/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>14/03/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Andrew Baillie</name>
      <address>Psychology Department
Macquarie University NSW 2109</address>
      <phone>02 9850 9436</phone>
      <fax />
      <email>andrew.baillie@mq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Andrew Baillie</name>
      <address>Psychology Department
Macquarie University NSW 2109</address>
      <phone>02 9850 9436</phone>
      <fax />
      <email>andrew.baillie@mq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>